Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia. 2001

M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo

UI MeSH Term Description Entries
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma
D018365 Neoplasm, Residual Remnant of a tumor or cancer after primary, potentially curative therapy. Minimal Residual Disease,Residual Cancer,Residual Tumor,Minimal Disease, Residual,Residual Disease, Minimal,Residual Neoplasm,Residual Tumour,Cancer, Residual,Minimal Residual Diseases,Residual Cancers,Residual Minimal Disease,Residual Minimal Diseases,Residual Neoplasms,Residual Tumors,Residual Tumours,Tumour, Residual

Related Publications

M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
September 2003, Leukemia & lymphoma,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
March 2013, Leukemia,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
March 2002, Blood,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
February 2020, International journal of molecular sciences,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
December 2017, Clinics in laboratory medicine,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
January 2017, Medical journal, Armed Forces India,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
August 1995, Blood,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
November 2008, Cytometry. Part B, Clinical cytometry,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
January 1994, Leukemia & lymphoma,
M Krampera, and O Perbellini, and A Maggioni, and F Scognamiglio, and G Todeschini, and G Pizzolo
January 2020, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Copied contents to your clipboard!